DIABETES RESEARCH AND CLINICAL PRACTICE, vol.106, no.2, pp.295-302, 2014 (SCI-Expanded)
Aims: We aimed to investigate the pharmacological efficiency of metformin on asymmetric dimethylarginine (ADMA) metabolism in inflammation caused by the lipopolysaccharide (LPS)/D-galactosamine (D-GalN) treatment.